OSCR

Oscar Health, Inc. Announces New Class of Culturally Competent Care Grantees to Help Underserved Communities

Retrieved on: 
Tuesday, October 11, 2022
Other Health, Managed Care, General Health, LGBTQ+, Philanthropy, Oncology, Consumer, Health Technology, Health Insurance, Women, Other Philanthropy, Health, CA, Color, BEA, Small group, OSCR, Woman, Organization, NYSE, Health, Patient, Program, Entrepreneurship, Individual, Collection, Meanings of minor planet names: 10001–11000, Mandarin Oriental Hotel Group, Software, Language, World, Medicare, Breast cancer, CEO, MHC, NCQA, Culture, POC, Medicine, Birth control

Oscar defines culturally competent care as providing care to patients with diverse values, beliefs and behaviors, including tailoring delivery to meet patients social, cultural, and linguistic needs.

Key Points: 
  • Oscar defines culturally competent care as providing care to patients with diverse values, beliefs and behaviors, including tailoring delivery to meet patients social, cultural, and linguistic needs.
  • Far too often, it is the lack of culturally competent care options across the U.S. that lead to negative health outcomes for underserved communities.
  • At Oscar, we share their commitment to making healthcare both affordable and accessible to all, especially to those in underserved communities.
  • Through this program, Oscar leverages its member experience and technological expertise to help people find culturally competent and sensitive care.

DNAnexus Selected as Platform Provider of the Trusted Research Environment for UK’s Largest Health Research Program

Retrieved on: 
Monday, September 12, 2022
Technology, Biotechnology, Health, Biometrics, Pharmaceutical, Research, Software, Infectious Diseases, General Health, Genetics, Health Technology, Science, Data Management, Security, Adult, University, Health, Volunteering, Safety, NHS, Confidentiality, Organic, Charity Commission for England and Wales, Privacy, Future, Population, Industry, Environment, Program, Government, CEO, UK Biobank, Office of the Scottish Charity Regulator, Royal commission, Research, Drug discovery, View, OSCR, Medical device, Pharmaceutical industry, DNAnexus

Andrew Roddam, CEO of Our Future Health, said: Were delighted that DNAnexus will be delivering our trusted research environment.

Key Points: 
  • Andrew Roddam, CEO of Our Future Health, said: Were delighted that DNAnexus will be delivering our trusted research environment.
  • We are very excited that this ambitious health research program, the largest of its kind, will utilize the power of our industry-leading biomedical data analysis platform and expertise, said Richard Daly, CEO at DNAnexus.
  • It aims to be the UKs largest health research programme, bringing people together to develop new ways to prevent, detect and treat disease.
  • Our Future Health is a member of the UK Health Data Research Alliance, the independent alliance of leading healthcare and research organisations establishing best practice for the ethical use of UK health data for research at scale.

Oscar Health, Inc. Announces Participation at Upcoming Conferences

Retrieved on: 
Thursday, September 1, 2022
General Health, Health Insurance, Health, Other Health, Software, Medicare, Conference, OSCR, Small group, CEO, CFO, NYSE, Oscar, Health, Individual

All interested parties are invited to listen to a webcast of these presentations by visiting www.ir.hioscar.com and selecting the Events & Presentations link.

Key Points: 
  • All interested parties are invited to listen to a webcast of these presentations by visiting www.ir.hioscar.com and selecting the Events & Presentations link.
  • Oscar Health, Inc. (Oscar) is the first health insurance company built around a full stack technology platform and a relentless focus on serving its members.
  • At Oscar, our mission is to make a healthier life accessible and affordable for all.
  • Headquartered in New York City, Oscar has been challenging the health care system's status quo since our founding in 2012.

Cigna + Oscar Expands Footprint to Bring Small Businesses in Philadelphia Access to Cost-Effective Health Plans

Retrieved on: 
Monday, August 15, 2022
Other Health, Health, Professional Services, Small Business, Health Insurance, Express Scripts, Risk, Health, Pharmacy, Small group, Medicare, NYSE, Central, Growth, Individual, Facebook, Hospital, Prescription, Oscar, Workforce, Cigna, CPF, OSCR, Small business, Twitter, Partnership, Corporation, CI, Software, Solution, Risk management, Health insurance

In this dynamic environment, small businesses need health plans that are affordable, predictable, and simple.

Key Points: 
  • In this dynamic environment, small businesses need health plans that are affordable, predictable, and simple.
  • With this expansion, Cigna + Oscar health plans are now able to help small businesses in Philadelphia provide their employees with access to quality care at a more affordable cost.
  • We are excited to bring this momentum to Philadelphia and look forward to working with small businesses throughout the area.
  • Oscar Health, Inc. (Oscar) is the first health insurance company built around a full stack technology platform and a relentless focus on serving its members.

Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Oscar Health, Inc. (OSCR) Investors of Class Action and Last Few Hours to Actively Participate

Retrieved on: 
Monday, July 11, 2022
Legal, Professional Services, Registration statement, Complaint, Prospectus, COVID-19, COVID, OSCR, Securities Exchange Act of 1934, NYSE, LLC, Coastal submarine, Register, Review, Risk, Court, Growth, COVID-19 testing, Security (finance)

Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/oscr .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/oscr .
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1933.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.
  • Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits.

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Oscar Health, Inc. with Losses of $100,000 to Contact the Firm

Retrieved on: 
Monday, July 11, 2022
Class Action Lawsuit, Professional Services, Legal, Certification, COVID-19, OSCR, NYSE, IPO, Company, Ethics, Oscar, Risk, Suite, COVID-19 testing, Security (finance)

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR ) for violations of the securities laws.

Key Points: 
  • The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR ) for violations of the securities laws.
  • The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

OSCR FINAL DEADLINE TOMORROW: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Oscar Health, Inc. Investors to Secure Counsel Before Important July 11 Deadline in Securities Class Action – OSCR

Retrieved on: 
Sunday, July 10, 2022
Titan, I-Space (Chinese company), Advertising, LinkedIn, Court, Register, TO, WHY, GLOBE, COVID-19, Growth, OSCR, Risk, Prospectus, COVID-19 testing, THE, Registration statement, NYSE, Oscar Health, Facebook, Twitter, SEP, Security (finance), Tobacco

WHAT TO DO NEXT: To join the Oscar class action, go to https://rosenlegal.com/submit-form/?case_id=6200 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Oscar class action, go to https://rosenlegal.com/submit-form/?case_id=6200 or call Phillip Kim, Esq.
  • If you wish to serve as lead plaintiff, you must move the Court no later than July 11, 2022.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Final Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed against Oscar Health, Inc. (OSCR)

Retrieved on: 
Sunday, July 10, 2022
Insurance, Ratio, Fraud, Lead, LLP, COVID, GLOBE, COVID-19, OSCAR, OSCR, District court, COVID-19 testing, NYSE, CLASS, COPY, MLR, News, IPO, Private investigator, Security (finance), Pharmaceutical industry, Architecture

Kessler Topaz Meltzer & Check, LLP encourages Oscar investors who have suffered significant losses to contact the firm directly to acquire more information.

Key Points: 
  • Kessler Topaz Meltzer & Check, LLP encourages Oscar investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.
  • ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP
    Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world.
  • The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Oscar Health, Inc. of Class Action Lawsuit and Upcoming Deadline – OSCR

Retrieved on: 
Saturday, July 9, 2022
Offering, Securities Act of 1933, Court, LLP, Register, COVID, GLOBE, COVID-19, Exercise, Growth, OSCR, Company, District court, Risk, U.S. Securities and Exchange Commission, Prospectus, Pomerantz, COVID-19 testing, Ext, Person, NYSE, Registration statement, Complaint, Lists of action films, Coastal submarine, MLR, News, IPO, Security (finance), Pharmaceutical industry

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.

Key Points: 
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • In the IPO, the Company sold 36,391,946 shares of Class A common stock at a price of $39.00 per share.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

OSCAR HEALTH 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Oscar Health, Inc. - OSCR

Retrieved on: 
Saturday, July 9, 2022
Legal, Professional Services, Ratio, Court, COVID, Special warfare combatant-craft crewmen, OSCR, Oscar Health, Company, District court, Risk, KSF, LLC, NYSE, News, IPO, Insurance

These actions are pending in the United States District Court for the Southern District of New York.

Key Points: 
  • These actions are pending in the United States District Court for the Southern District of New York.
  • Oscar Health and certain of its executives are charged with failing to disclose material information in its IPO Registration Statement, violating federal securities laws.
  • On this news, shares of Oscar Health fell $4.05 per share, or 24.5%, to close at $12.47 per share on November 11, 2021.
  • About Kahn Swick & Foti, LLC
    KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nations premier boutique securities litigation law firms.